PHK
WST icon

Point72 Hong Kong’s West Pharmaceutical WST Stock Holding History

Point72 Hong Kong’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$269K Sell
1,027
-5,683
-85% -$1.38M 0.01% 298
2025
Q2 		$1.47M Buy
+6,710
New +$1.43M 0.1% 176
2024
Q1 		– Sell
-34,766
Closed -$12.2M – 827
2023
Q4 		$12.2M Buy
+34,766
New +$12.3M 0.73% 30
2022
Q4 		– Sell
-15,678
Closed -$3.86M – 1702
2022
Q3 		$3.86M Buy
15,678
+3,002
+24% +$915K 0.13% 192
2022
Q2 		$3.83M Buy
+12,676
New +$4.12M 0.14% 188
2022
Q1 		– Sell
-955
Closed -$448K – 2381
2021
Q4 		$448K Sell
955
-2,507
-72% -$1.08M 0.02% 800
2021
Q3 		$1.47M Buy
3,462
+1,232
+55% +$519K 0.05% 587
2021
Q2 		$801K Buy
+2,230
New +$737K 0.03% 777
2020
Q3 		– Sell
-9,158
Closed -$2.08M – 1577
2020
Q2 		$2.08M Buy
9,158
+8,379
+1,076% +$1.65M 0.23% 107
2020
Q1 		$119K Buy
+779
New +$120K 0.05% 166
2019
Q4 		– Sell
-2,597
Closed -$368K – 1494
2019
Q3 		$368K Buy
2,597
+528
+26% +$72.7K 0.11% 148
2019
Q2 		$259K Buy
2,069
+1,954
+1,699% +$231K 0.07% 261
2019
Q1 		$13K Buy
+115
New +$12K 0.01% 734
2018
Q1 		– Sell
-89
Closed -$9K – 1186
2017
Q4 		$9K Buy
+89
New +$8.73K 0.01% 514
2017
Q3 		– Sell
-133
Closed -$13K – 1091
2017
Q2 		$13K Sell
133
-23
-15% -$2.12K 0.01% 439
2017
Q1 		$13K Buy
+156
New +$13K 0.02% 474
2016
Q4 		– Sell
-699
Closed -$52K – 1059
2016
Q3 		$52K Buy
699
+99
+17% +$7.86K 0.03% 464
2016
Q2 		$46K Buy
+600
New +$43.7K 0.05% 269

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Point72 Hong Kong's WST Position: Q3 2025 in Review

Point72 Hong Kong reduced its West Pharmaceutical (WST) stake by 85% in Q3 2025, selling an estimated $1.38M and leaving 1,027 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #298.

Point72 Hong Kong first reported a position in WST in Q2 2016 and has held it in 18 quarters since. The position peaked at $12.2M in Q4 2023. 757 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Point72 Hong Kong held 1,027 shares of West Pharmaceutical worth $269K as of Q3 2025.
  • Point72 Hong Kong sold 5,683 West Pharmaceutical shares in Q3 2025, an estimated $1.38M.
  • West Pharmaceutical made up 0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #298 holding.
  • Point72 Hong Kong first reported a position in West Pharmaceutical in Q2 2016 and has held it in 18 quarters since.
  • Point72 Hong Kong's West Pharmaceutical position peaked at $12.2M in Q4 2023.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.